期刊文献+

黏膜给药系统的研究进展 被引量:1

Progress of Buccal Mucosa Drug Delivery System
原文传递
导出
摘要 目的介绍传统剂型,新技术,新方法在黏膜给药系统上的研究进展。方法综述了凝胶剂、喷雾剂、气雾剂、粉雾剂等传统剂型;微球、脂质体、纳米粒、乳剂、原位凝胶等新技术以及吸收促进剂、生物黏附剂、前体药物、酶抑制剂等方法在促进药物黏膜吸收方面的进展。结果国内外对这些剂型、方法、技术等已经进行了广泛和深入的研究,取得了较大的进展。结论黏膜给药系统已成为目前研究的热点,它是传统给药方式的补充,具有广阔的应用前景。同时,为了进一步促进黏膜给药系统的发展,对安全、低毒、有效的吸收促进剂和新型载药体系的开发仍将是今后研究的主要方向。 OBJECTIVE To introduce the traditional formulations, new technologies, new methods applied in the mucosal drug delivery systems. METHODS Review gels, sprays, aerosols, dry powder inhalations, microspheres, liposomes, nanoparticles, emulsion, in situ gel, absorption enhancers, bioadhesive agents, prodrug, enzyme inhibitors in the promotion of mucosal drug delivery systems. RESULTS Formulations, methods and techniques have been extensively studied, and progresses have been made in recent years. COCLUSION Mucosal delivery system has become a research hotspot and it has broad application prospects to replace the traditional delivery system. Exploitation of low toxicity and effective absorption enhancers and new drug carrier systems will be the main aspects to develop the mucosal drug delivery system so as to promote the penetration of the drug.
出处 《中国现代应用药学》 CAS CSCD 2012年第3期214-218,共5页 Chinese Journal of Modern Applied Pharmacy
基金 浙江省科技厅科技计划项目(2007C23003)
关键词 黏膜 剂型 药物制剂 mucosa formulation pharmaceutical preparation
  • 相关文献

参考文献41

  • 1CAI Z,SONG X,SUN F,et al.Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodin[J].AAPS PharmSciTech,2011,12(4):1102-1109.
  • 2HEEMSTRA L B,FINNIN B C,NICOLAZZO J A.The buccal mucosa as an alternative route for the systemic delivery of risperidone[J].J Pharm Sci,2010,99(11):4584-4592.
  • 3FISHER A,WATLING M,SMITH A,et al.Pharmacokinetics and relative bioavailability of fentanyl pectin nasal spray100-800μg in healthy volunteers[J].Int J Clin Pharmacol Ther,2010,48(12):860-867.
  • 4WANG H W,CHOU Y L,CHU Y H.Azelastine nasal spray inhibiting parasympathetic function of tracheal smooth muscle[J].Rhinology,2010,48(2):211-215.
  • 5HU K L,MEI N,FENG L,et al.Hydrophilic nasal gel of lidocaine hydrochloride.2nd communication:Improved bioavailability and brain delivery in rats with low ciliotoxicity[J].Arzneimittelforschung,2009,59(12):635-640.
  • 6POZZILLI P,RASKIN P,PARKIN C G.Review of clinical trials:update on oral insulin spray formulation[J].Diabetes Obes Metab,2010,12(2):91-96.
  • 7吴云娟,沙先谊,李2婵,方晓玲.星点设计效应面优化法优化三七总皂苷鼻腔用粉雾剂[J].中成药,2005,27(1):10-15. 被引量:24
  • 8MATSUYAMA T,MORITA T,HORIKIRI Y,et al.Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-L-cysteine as a mucolytic agent[J].J Control Release,2006,115(2):183-188.
  • 9RUSSO P,SACCHETTI C,PASQUALI I,et al.Primary microparticles and agglomerates of morphine for nasal insufflation[J].J Pharm Sci,2006,95(12):2553-2561.
  • 10BELGAMWAR V S,PATEL H S,JOSHI A S.Design and development of nasal mucoadhesive microspheres containing tramadol HCl for CNS targeting[J].Drug Deliv,2011,25(2):236-245.

二级参考文献25

  • 1许清芳,方晓玲,陈道峰,李珺婵.三七总皂苷鼻腔用制剂的研究[J].药学学报,2003,38(11):859-862. 被引量:27
  • 2王朝晖,鹿峪峰,韩玉珉.重组水蛭素HV2的稳定性[J].生物化学杂志,1995,11(3):321-327. 被引量:7
  • 3蒋新国,崔景斌,方晓玲,韦阳,奚念朱.药物的鼻粘膜纤毛毒性及评价方法[J].药学学报,1995,30(11):848-853. 被引量:87
  • 4张玉杰,张强,侯俊玲,王筱亮,陈明霞.重组水蛭素-2鼻腔喷雾剂的药代动力学和药效学[J].药学学报,2006,41(3):268-271. 被引量:7
  • 5Suzuki Y, Makino Y. Mucosal drug delivery using cellulose derivatives as a functional polymer [ J ]. Control release, 1999, 62 ( 1 -2) :101-107.
  • 6Batchelor H K, Banning D, Dettmar P W, et al. An in vitro mucosal model for prediction of the bioadhesion of alginate solutions to the oesophagus [ J ]. J of Pharma ,2002 ,238 ( 1-2 ): 123-132.
  • 7Chen XL,Jin YY,Tang G.Materia Medica New Edition (新编药物学)[M].15th ed,Beijing:People's Health Press,2003:275.
  • 8Illum L.Is nose-to-brain transport of drugs in man a reality?[J].J Pharm Pharmacol,2004,56:3-17.
  • 9Fehm HL,Perras B,Smolnik R,et al.Manipulating neuropeptidergic pathways in humans:a novel approach to neuropharmacology?[J].Eur J Pharmacol,2000,405:43-54.
  • 10Quay SC.Successful delivery of apomorphine to the brain following intranasal administration demonstrated in clinical study[J].PRNewswire,2001,July 18th.

共引文献95

同被引文献19

  • 1杜玍妮,高永良,潘卫三.盐酸纳美芬鼻腔喷雾剂纤毛毒性影响因素的考察与评价[J].中国新药杂志,2007,16(15):1199-1202. 被引量:5
  • 2杜生妮.盐酸纳美芬鼻腔给药系统的设计与评价[D].沈阳,沈阳药科大学,2007.
  • 3ZHAO JH, FU JH, WANG SM, et al. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization [ J ]. lnt J Pharm, 2007,337 ( 1 - 2 ) : 88 - 101.
  • 4ISHIGURO H, IKEDA T, ABE A, et al. Antiarrhythmic effect of bisoprolol, a highly selective ,8-Blocker, in patients with paroxys- mal atrial fibrillation [ J ]. Int Heart J,2008,49 (3) :281 -293.
  • 5ILLUM L. Nasal drug delivery-recent developments and future prospects [ J ]. J Control Release,2012,16 l ( 2 ) : 254 - 263.
  • 6COSTANTINO HR,ILLUM L,BRANDT G,et al. Intranasal de- livery: physicochemical and therapeutic aspects [ J ]. lnt J Pharm ,2007,337 ( 1 - 2 ) : 1 - 24.
  • 7GU FG, CUI FD, GAO YL. Preparation of PGE-hydroxylpropyl- 13-cyclodextrin complex and its nasal delivery in rats [ J ]. lnt J Pharm,2005,290(1 -2) :101 - 108.
  • 8HASCHKE M,SUTER K, HOFMANN S,et al. Pharmacokinetics and pharmacodynamics of nasally delivered midazolam [ J ]. Br J Clin Pharmacol,2010,69 ( 6 ) : 607 - 616.
  • 9JOSHI SJ, KARBHARI PA, BHOIR SI, et al. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and bydrochlo- rothiazide in tablet formulation [ J ]. J Pharm Biomed Anal, 2010, 52(3) :362 -371.
  • 10BEHL CR, PIMPLASKAR HK, SILENO AP, et al. Effects of physicochemical properties and other factors on systemic nasal drug delivery [ J ]. Adv Drug Del Rev, 1998,29 ( 1 ) : 89 - 116.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部